About UCSF Search UCSF UCSF Medical Center

Robert Kerlan, MD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
kerlan_robert

Professor, Department of Radiology, UCSF

Phone: (415) 353-1300 (appts)
Box 0628, UCSF
San Francisco, CA 94143-0628

View on UCSF Profiles


Additional Websites


Selected Publications

  1. Kuo YC, Kohi MP, Naeger DM, Tong RT, Kolli KP, Taylor AG, Laberge JM, Kerlan RK, Fidelman N. Efficacy of TACE in TIPS patients: comparison of treatment response to chemoembolization for hepatocellular carcinoma in patients with and without a transjugular intrahepatic portosystemic shunt. Cardiovasc Intervent Radiol. 2013 Oct; 36(5):1336-43.
    View on PubMed
  2. Veal DR, Lee AY, Kerlan RK, Gordon RL, Fidelman N. Outcomes of metallic biliary stent insertion in patients with malignant bilobar obstruction. J Vasc Interv Radiol. 2013 Jul; 24(7):1003-10.
    View on PubMed
  3. Kohi MP, Fidelman N, Kerlan RK. Reply to ?Re: Hepatotoxicity after transarterial chemoembolization and transjugular intrahepatic portosystemic shunt: do two rights make a wrong?? J Vasc Interv Radiol. 2013 Jul; 24(7):1076.
    View on PubMed
  4. Olorunsola OG, Kohi MP, Fidelman N, LaBerge JM, Kerlan RK. Failure of filter reexpansion during unsuccessful retrieval of Option inferior vena cava filter. J Vasc Interv Radiol. 2013 Jul; 24(7):1065-7.
    View on PubMed
  5. Johnson DT, Durack JC, Fidelman N, Kerlan RK, LaBerge JM. Distribution of reported StarClose SE vascular closure device complications in the manufacturer and user facility device experience database. J Vasc Interv Radiol. 2013 Jul; 24(7):1051-6.
    View on PubMed
  6. Tong RT, Kohi M, Fidelman N, Kuo YC, Foster R, Peled A, Kolli KP, Taylor AG, LaBerge JM, Kerlan RK. Clinical outcomes of percutaneous drainage of breast fluid collections after mastectomy with expander-based breast reconstruction. J Vasc Interv Radiol. 2013 Sep; 24(9):1369-74.
    View on PubMed
  7. Marshall D, Laberge JM, Firetag B, Miller T, Kerlan RK. The changing face of percutaneous image-guided biopsy: molecular profiling and genomic analysis in current practice. J Vasc Interv Radiol. 2013 Aug; 24(8):1094-103.
    View on PubMed
  8. Durack JC, Wang JH, Sebro R, Zhang KK, Hoch S, Kerlan RK. Prospective evaluation of absorbable gastropexy anchor indwelling time in 33 patients. J Vasc Interv Radiol. 2013 Sep; 24(9):1377-80.
    View on PubMed
  9. Kohi MP, Naeger DM, Kukreja J, Fidelman N, Laberge JM, Gordon RL, Kerlan RK. Preoperative CT-Guided percutaneous wire localization of ground glass pulmonary nodules with a modified Kopans wire. J Thorac Dis. 2013 Apr; 5(2):E31-4.
    View on PubMed
  10. Burke C, Taylor AG, Ring EJ, Kerlan RK. Creation of a percutaneous mesocaval shunt to control variceal bleeding in a child. Pediatr Radiol. 2013 Sep; 43(9):1218-20.
    View on PubMed
  11. Olorunsola OG, Kohi MP, Fidelman N, Westphalen AC, Kolli PK, Taylor AG, Gordon RL, LaBerge JM, Kerlan RK. Caval penetration by retrievable inferior vena cava filters: a retrospective comparison of Option and G√ľnther Tulip filters. J Vasc Interv Radiol. 2013 Apr; 24(4):566-71.
    View on PubMed
  12. Garwood ER, Fidelman N, Hoch SE, Kerlan RK, Yao FY. Morbidity and mortality following transarterial liver chemoembolization in patients with hepatocellular carcinoma and synthetic hepatic dysfunction. Liver Transpl. 2013 Feb; 19(2):164-73.
    View on PubMed
  13. Arrayeh E, Fidelman N, Gordon RL, LaBerge JM, Kerlan RK, Klimov A, Bloom AI. Transcatheter arterial embolization for upper gastrointestinal nonvariceal hemorrhage: is empiric embolization warranted? Cardiovasc Intervent Radiol. 2012 Dec; 35(6):1346-54.
    View on PubMed
  14. Kohi MP, Fidelman N, Naeger DM, LaBerge JM, Gordon RL, Kerlan RK. Hepatotoxicity after transarterial chemoembolization and transjugular intrahepatic portosystemic shunt: do two rights make a wrong? J Vasc Interv Radiol. 2013 Jan; 24(1):68-73.
    View on PubMed
  15. Lee AY, Gregorius J, Kerlan RK, Gordon RL, Fidelman N. Percutaneous transhepatic balloon dilation of biliary-enteric anastomotic strictures after surgical repair of iatrogenic bile duct injuries. PLoS One. 2012; 7(10):e46478.
    View on PubMed
  16. Fidelman N, Kwan SW, LaBerge JM, Gordon RL, Ring EJ, Kerlan RK. The transjugular intrahepatic portosystemic shunt: an update. AJR Am J Roentgenol. 2012 Oct; 199(4):746-55.
    View on PubMed
  17. Durack JC, Hope TA, Seo Y, Saeed M, He J, Wilson MW, Kerlan RK, Ring EJ. Intravenous vasopressin for the prevention of nontarget gastrointestinal embolization during liver-directed cancer treatment: experimental study in a porcine model. J Vasc Interv Radiol. 2012 Nov; 23(11):1505-12.
    View on PubMed
  18. Park SJ, Freise CE, Hirose R, Kerlan RK, Yao FY, Roberts JP, Vagefi PA. Risk factors for liver transplant waitlist dropout in patients with hepatocellular carcinoma. Clin Transplant. 2012 Jul-Aug; 26(4):E359-64.
    View on PubMed
  19. Kwan SW, Fidelman N, Ma E, Kerlan RK, Yao FY. Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: a radiological-pathological correlation. Liver Transpl. 2012 Jun; 18(6):727-36.
    View on PubMed
  20. Kerlan RK, Laberge JM. Intranodal lymphangiography: coming soon to a hospital near you. J Vasc Interv Radiol. 2012 May; 23(5):617.
    View on PubMed

Go to UCSF Profiles, powered by CTSI